Healthcare’s eyes are on private equity. Here’s why.

Private equity has been under the microscope recently as its role in healthcare is being questioned by federal agencies and physicians alike. 

Advertisement

According to a study in JAMA Network Internal Medicine, more than 60% of physicians feel negatively about private equity’s role in healthcare. Just 10.5% of physicians said they view private equity as positive.

A study published in the Journal of the American Medical Association found private equity-backed hospitals may have worse quality of inpatient care. Findings like this could contribute to physicians’ wariness toward private equity.

Though private equity has a strong presence throughout several areas of healthcare, some specialties are seeing more activity than others. Gastroenterology saw a decrease in private equity activity in 2023 compared to 2022, while cardiology saw an increase in deals. 

Overall, private equity deals were down 16.2% in 2023.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Private Equity

Advertisement

Comments are closed.